Predictability of clinical outcomes after external beam radiotherapy for hepatocellular carcinoma according to tumor marker dynamics
Signal changes after high dose irradiation on MRI make it difficult to assess the therapeutic response of hepatocellular carcinoma (HCC). To overcome the limitation of imaging work-up, our study predicted clinical outcomes through tumor marker dynamics in HCC after external beam radiotherapy (EBRT)....
Gespeichert in:
| Veröffentlicht in: | PloS one Jg. 20; H. 5; S. e0323450 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
Public Library of Science
20.05.2025
Public Library of Science (PLoS) |
| Schlagworte: | |
| ISSN: | 1932-6203, 1932-6203 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Signal changes after high dose irradiation on MRI make it difficult to assess the therapeutic response of hepatocellular carcinoma (HCC). To overcome the limitation of imaging work-up, our study predicted clinical outcomes through tumor marker dynamics in HCC after external beam radiotherapy (EBRT). As a single-center retrospective study, those who underwent conventional fractionated EBRT for viable HCC from 2010 to 2021 were analyzed. Patients with elevated tumor markers of AFP ≥ 10 ng/ml or PIVKA-II ≥ 30 mAU/ml before EBRT were enrolled. Remission of AFP, PIVKA-II, and MoRAL score (=11*√PIVKA-II + 2*√AFP) from pre-EBRT to post-EBRT at 1 month and 3 months was examined. For 1-year and 2-years OS, variables of tumor markers were examined using the receiver operation characteristics (ROC). Multivariate analyses of Cox-regression for OS were conducted. Among 111 patients, 34 patients were estimated to survive more than 2-years. In multivariate analyses for OS, tumor number ( P = 0.004), portal vein tumor thrombus ( P = 0.004), and Barcelona liver cancer staging ( P < 0.001) were found to be significant. For 2-years OS, the degree of AFP remission at 3 months (rAFP_3M) had an AUC of 0.852 (95% CI: 0.758–0.946, P < 0.001), a sensitivity of 85.5%, and a specificity of 82.6% with a cut-off value of 3.7%. MoRAL score at 3 months (MoRAL_3M) had an AUC of 0.814 (95% CI: 0.728–0.900, P = 0.000), a sensitivity of 76.5%, and a specificity of 77.8% with a cut-off value of 111.64. In new multivariate analyses including the above significant factors plus either rAFP_3M or MoRAL_3M, rAFP_3M ( P < 0.001) and MoRAL_3M ( P < 0.001) were found to be independent prognostic factors in each model. This study confirmed the importance of the changed tumor marker after EBRT rather than the baseline value. Dynamic change of AFP and MoRAL score at post-EBRT 3 months could be recommended as potential indicators for clinical outcomes. |
|---|---|
| AbstractList | Signal changes after high dose irradiation on MRI make it difficult to assess the therapeutic response of hepatocellular carcinoma (HCC). To overcome the limitation of imaging work-up, our study predicted clinical outcomes through tumor marker dynamics in HCC after external beam radiotherapy (EBRT). As a single-center retrospective study, those who underwent conventional fractionated EBRT for viable HCC from 2010 to 2021 were analyzed. Patients with elevated tumor markers of AFP ≥ 10 ng/ml or PIVKA-II ≥ 30 mAU/ml before EBRT were enrolled. Remission of AFP, PIVKA-II, and MoRAL score (=11*√PIVKA-II + 2*√AFP) from pre-EBRT to post-EBRT at 1 month and 3 months was examined. For 1-year and 2-years OS, variables of tumor markers were examined using the receiver operation characteristics (ROC). Multivariate analyses of Cox-regression for OS were conducted. Among 111 patients, 34 patients were estimated to survive more than 2-years. In multivariate analyses for OS, tumor number ( P = 0.004), portal vein tumor thrombus ( P = 0.004), and Barcelona liver cancer staging ( P < 0.001) were found to be significant. For 2-years OS, the degree of AFP remission at 3 months (rAFP_3M) had an AUC of 0.852 (95% CI: 0.758–0.946, P < 0.001), a sensitivity of 85.5%, and a specificity of 82.6% with a cut-off value of 3.7%. MoRAL score at 3 months (MoRAL_3M) had an AUC of 0.814 (95% CI: 0.728–0.900, P = 0.000), a sensitivity of 76.5%, and a specificity of 77.8% with a cut-off value of 111.64. In new multivariate analyses including the above significant factors plus either rAFP_3M or MoRAL_3M, rAFP_3M ( P < 0.001) and MoRAL_3M ( P < 0.001) were found to be independent prognostic factors in each model. This study confirmed the importance of the changed tumor marker after EBRT rather than the baseline value. Dynamic change of AFP and MoRAL score at post-EBRT 3 months could be recommended as potential indicators for clinical outcomes. Signal changes after high dose irradiation on MRI make it difficult to assess the therapeutic response of hepatocellular carcinoma (HCC). To overcome the limitation of imaging work-up, our study predicted clinical outcomes through tumor marker dynamics in HCC after external beam radiotherapy (EBRT). As a single-center retrospective study, those who underwent conventional fractionated EBRT for viable HCC from 2010 to 2021 were analyzed. Patients with elevated tumor markers of AFP [greater than or equal to] 10 ng/ml or PIVKA-II [greater than or equal to] 30 mAU/ml before EBRT were enrolled. Remission of AFP, PIVKA-II, and MoRAL score (=11*[square root]PIVKA-II + 2*[square root]AFP) from pre-EBRT to post-EBRT at 1 month and 3 months was examined. For 1-year and 2-years OS, variables of tumor markers were examined using the receiver operation characteristics (ROC). Multivariate analyses of Cox-regression for OS were conducted. Among 111 patients, 34 patients were estimated to survive more than 2-years. In multivariate analyses for OS, tumor number (P = 0.004), portal vein tumor thrombus (P = 0.004), and Barcelona liver cancer staging (P < 0.001) were found to be significant. For 2-years OS, the degree of AFP remission at 3 months (rAFP_3M) had an AUC of 0.852 (95% CI: 0.758-0.946, P < 0.001), a sensitivity of 85.5%, and a specificity of 82.6% with a cut-off value of 3.7%. MoRAL score at 3 months (MoRAL_3M) had an AUC of 0.814 (95% CI: 0.728-0.900, P = 0.000), a sensitivity of 76.5%, and a specificity of 77.8% with a cut-off value of 111.64. In new multivariate analyses including the above significant factors plus either rAFP_3M or MoRAL_3M, rAFP_3M (P < 0.001) and MoRAL_3M (P < 0.001) were found to be independent prognostic factors in each model. This study confirmed the importance of the changed tumor marker after EBRT rather than the baseline value. Dynamic change of AFP and MoRAL score at post-EBRT 3 months could be recommended as potential indicators for clinical outcomes. Signal changes after high dose irradiation on MRI make it difficult to assess the therapeutic response of hepatocellular carcinoma (HCC). To overcome the limitation of imaging work-up, our study predicted clinical outcomes through tumor marker dynamics in HCC after external beam radiotherapy (EBRT). As a single-center retrospective study, those who underwent conventional fractionated EBRT for viable HCC from 2010 to 2021 were analyzed. Patients with elevated tumor markers of AFP ≥ 10 ng/ml or PIVKA-II ≥ 30 mAU/ml before EBRT were enrolled. Remission of AFP, PIVKA-II, and MoRAL score (=11*√PIVKA-II + 2*√AFP) from pre-EBRT to post-EBRT at 1 month and 3 months was examined. For 1-year and 2-years OS, variables of tumor markers were examined using the receiver operation characteristics (ROC). Multivariate analyses of Cox-regression for OS were conducted. Among 111 patients, 34 patients were estimated to survive more than 2-years. In multivariate analyses for OS, tumor number (P = 0.004), portal vein tumor thrombus (P = 0.004), and Barcelona liver cancer staging (P < 0.001) were found to be significant. For 2-years OS, the degree of AFP remission at 3 months (rAFP_3M) had an AUC of 0.852 (95% CI: 0.758-0.946, P < 0.001), a sensitivity of 85.5%, and a specificity of 82.6% with a cut-off value of 3.7%. MoRAL score at 3 months (MoRAL_3M) had an AUC of 0.814 (95% CI: 0.728-0.900, P = 0.000), a sensitivity of 76.5%, and a specificity of 77.8% with a cut-off value of 111.64. In new multivariate analyses including the above significant factors plus either rAFP_3M or MoRAL_3M, rAFP_3M (P < 0.001) and MoRAL_3M (P < 0.001) were found to be independent prognostic factors in each model. This study confirmed the importance of the changed tumor marker after EBRT rather than the baseline value. Dynamic change of AFP and MoRAL score at post-EBRT 3 months could be recommended as potential indicators for clinical outcomes.Signal changes after high dose irradiation on MRI make it difficult to assess the therapeutic response of hepatocellular carcinoma (HCC). To overcome the limitation of imaging work-up, our study predicted clinical outcomes through tumor marker dynamics in HCC after external beam radiotherapy (EBRT). As a single-center retrospective study, those who underwent conventional fractionated EBRT for viable HCC from 2010 to 2021 were analyzed. Patients with elevated tumor markers of AFP ≥ 10 ng/ml or PIVKA-II ≥ 30 mAU/ml before EBRT were enrolled. Remission of AFP, PIVKA-II, and MoRAL score (=11*√PIVKA-II + 2*√AFP) from pre-EBRT to post-EBRT at 1 month and 3 months was examined. For 1-year and 2-years OS, variables of tumor markers were examined using the receiver operation characteristics (ROC). Multivariate analyses of Cox-regression for OS were conducted. Among 111 patients, 34 patients were estimated to survive more than 2-years. In multivariate analyses for OS, tumor number (P = 0.004), portal vein tumor thrombus (P = 0.004), and Barcelona liver cancer staging (P < 0.001) were found to be significant. For 2-years OS, the degree of AFP remission at 3 months (rAFP_3M) had an AUC of 0.852 (95% CI: 0.758-0.946, P < 0.001), a sensitivity of 85.5%, and a specificity of 82.6% with a cut-off value of 3.7%. MoRAL score at 3 months (MoRAL_3M) had an AUC of 0.814 (95% CI: 0.728-0.900, P = 0.000), a sensitivity of 76.5%, and a specificity of 77.8% with a cut-off value of 111.64. In new multivariate analyses including the above significant factors plus either rAFP_3M or MoRAL_3M, rAFP_3M (P < 0.001) and MoRAL_3M (P < 0.001) were found to be independent prognostic factors in each model. This study confirmed the importance of the changed tumor marker after EBRT rather than the baseline value. Dynamic change of AFP and MoRAL score at post-EBRT 3 months could be recommended as potential indicators for clinical outcomes. |
| Audience | Academic |
| Author | Yim, Hyung Joon Jung, Young Kul Yoon, Won Sup Rim, Chai Hong Park, Sunmin Chung, Hwan Hoon |
| AuthorAffiliation | Cincinnati Children’s Hospital Medical Center, UNITED STATES OF AMERICA 2 Department of Internal Medicine, Ansan Hospital, College of Medicine, Korea University, Ansan, Gyeong-gi, Republic of Korea 3 Department of Radiology, Ansan Hospital, College of Medicine, Korea University, Ansan, Gyeong-gi, Republic of Korea 1 Department of Radiation Oncology, Ansan Hospital, College of Medicine, Korea University, Ansan, Gyeong-gi, Republic of Korea |
| AuthorAffiliation_xml | – name: 2 Department of Internal Medicine, Ansan Hospital, College of Medicine, Korea University, Ansan, Gyeong-gi, Republic of Korea – name: 3 Department of Radiology, Ansan Hospital, College of Medicine, Korea University, Ansan, Gyeong-gi, Republic of Korea – name: Cincinnati Children’s Hospital Medical Center, UNITED STATES OF AMERICA – name: 1 Department of Radiation Oncology, Ansan Hospital, College of Medicine, Korea University, Ansan, Gyeong-gi, Republic of Korea |
| Author_xml | – sequence: 1 givenname: Sunmin surname: Park fullname: Park, Sunmin – sequence: 2 givenname: Chai Hong surname: Rim fullname: Rim, Chai Hong – sequence: 3 givenname: Young Kul surname: Jung fullname: Jung, Young Kul – sequence: 4 givenname: Hyung Joon surname: Yim fullname: Yim, Hyung Joon – sequence: 5 givenname: Hwan Hoon surname: Chung fullname: Chung, Hwan Hoon – sequence: 6 givenname: Won Sup orcidid: 0000-0002-6098-1993 surname: Yoon fullname: Yoon, Won Sup |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40392828$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk12L1DAUhousuLuj_0A0IIhezJiPNmmvZFn8GFhY8es2nKbpTMa0mU1Sce794Wac7jKVvZBCW06evCfnzTnn2Unvep1lTwleECbIm40bfA92sU3hBWaU5QV-kJ2RitE5p5idHP2fZuchbDAuWMn5o-w0x6yiJS3Pst-fvG6MilAba-IOuRYpa3qjwCI3ROU6HRC0UXukf6V3yohqDR3y0BgX19rDdoda59FabyE6pa0dLHikwCvTuw4QKOV8Y_oVig7FoUtsB_5HUmx2PXRGhcfZwxZs0E_G7yz79v7d18uP86vrD8vLi6u54nke5wIawXRJC1xTXGlOFeWiwUwDLimpmqpoSwp1q8ualiC0ULgSSuSCC0oFrtgse37Q3VoX5GhgkIxiTgrGRZ6I5YFoHGzk1pt00p10YOTfgPMrCT4aZbUkjGNaUSBY5LkmBQhW16TmLW5bWhKctN6O2Ya6043SffRgJ6LTld6s5cr9lCRVR0TJksKrUcG7m0GHKDsT9g5Dr91wODhlBSM8oS_-Qe8vb6RWkCowfetSYrUXlRdljjkv94KzbHEPlZ5Gp9tK7daaFJ9seD3ZkJiYumUFQwhy-eXz_7PX36fsyyN2rcHGdXB2iMb1YQo-O7b6zuPbPk9AfgCUdyF43d4hBMv9ON3aJffjJMdxYn8A82ISRg |
| Cites_doi | 10.3350/cmh.2022.0294 10.14701/ahbps.22-044 10.1016/j.ejca.2008.10.026 10.1016/j.jhep.2018.03.019 10.1016/j.eclinm.2022.101391 10.3390/cancers15112927 10.3390/cancers11091295 10.1111/liv.14406 10.2147/JHC.S304439 10.1016/j.jhep.2017.01.012 10.1007/s00270-019-02191-z 10.3857/roj.2021.00934 10.1186/s12876-022-02596-0 10.1080/00365521.2019.1660403 10.3350/cmh.2022.0212 10.3390/cancers15153962 10.1053/j.seminoncol.2018.01.007 10.1016/j.cgh.2022.01.047 10.3390/cancers11111721 10.1016/j.jhep.2023.08.020 10.2147/JHC.S432011 10.3389/fonc.2022.906498 10.5732/cjc.014.10136 10.3748/wjg.v26.i4.393 10.1007/s12072-022-10423-7 10.1111/jgh.15722 10.1155/2023/1554599 |
| ContentType | Journal Article |
| Copyright | Copyright: © 2025 Park et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. COPYRIGHT 2025 Public Library of Science 2025 Park et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2025 Park et al 2025 Park et al 2025 Park et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: Copyright: © 2025 Park et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. – notice: COPYRIGHT 2025 Public Library of Science – notice: 2025 Park et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2025 Park et al 2025 Park et al – notice: 2025 Park et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0323450 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Opposing Viewpoints (Gale In Context) Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Computer Science Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database (Proquest) Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE Agricultural Science Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: ProQuest Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) |
| DocumentTitleAlternate | Tumor marker dynamics after radiotherapy in hepatocellular carcinoma |
| EISSN | 1932-6203 |
| ExternalDocumentID | 3206153674 oai_doaj_org_article_1360292a10744e15a73bb1b6f0ff2810 PMC12091783 A840668062 40392828 10_1371_journal_pone_0323450 |
| Genre | Journal Article |
| GeographicLocations | Slovenia United States--US |
| GeographicLocations_xml | – name: Slovenia – name: United States--US |
| GrantInformation_xml | – fundername: ; grantid: K2409151 and K2509141 |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACCTH ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AEUYN AFFHD AFKRA AFPKN AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAIFH BAWUL BBNVY BBTPI BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM ADRAZ ALIPV CGR CUY CVF ECM EIF IPNFZ NPM RIG BBORY PMFND 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO ESTFP FR3 GNUQQ H94 K9. KL. M7N P64 PKEHL PQEST PQUKI RC3 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c644t-7ad73e8250b209e62c267d03ea08219d95f82abfe8b28a7e7c097c74767227093 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001492085500049&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1932-6203 |
| IngestDate | Thu Aug 21 00:57:11 EDT 2025 Fri Oct 03 12:43:02 EDT 2025 Tue Nov 04 02:04:50 EST 2025 Fri Sep 05 16:05:07 EDT 2025 Tue Oct 07 08:11:00 EDT 2025 Sat Nov 29 13:48:02 EST 2025 Sat Nov 29 10:28:07 EST 2025 Wed Nov 26 10:45:50 EST 2025 Wed Nov 26 10:45:44 EST 2025 Tue Jun 03 02:17:34 EDT 2025 Mon Jul 21 06:05:00 EDT 2025 Sat Nov 29 07:52:49 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| License | Copyright: © 2025 Park et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c644t-7ad73e8250b209e62c267d03ea08219d95f82abfe8b28a7e7c097c74767227093 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: The authors have declared that no competing interests exist. |
| ORCID | 0000-0002-6098-1993 |
| OpenAccessLink | https://doaj.org/article/1360292a10744e15a73bb1b6f0ff2810 |
| PMID | 40392828 |
| PQID | 3206153674 |
| PQPubID | 1436336 |
| PageCount | e0323450 |
| ParticipantIDs | plos_journals_3206153674 doaj_primary_oai_doaj_org_article_1360292a10744e15a73bb1b6f0ff2810 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12091783 proquest_miscellaneous_3206235316 proquest_journals_3206153674 gale_infotracmisc_A840668062 gale_infotracacademiconefile_A840668062 gale_incontextgauss_ISR_A840668062 gale_incontextgauss_IOV_A840668062 gale_healthsolutions_A840668062 pubmed_primary_40392828 crossref_primary_10_1371_journal_pone_0323450 |
| PublicationCentury | 2000 |
| PublicationDate | 20250520 |
| PublicationDateYYYYMMDD | 2025-05-20 |
| PublicationDate_xml | – month: 5 year: 2025 text: 20250520 day: 20 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2025 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | JS Norman (pone.0323450.ref028) 2023; 79 L Guo (pone.0323450.ref006) 2022; 16 Y Chang (pone.0323450.ref021) 2019; 11 YY Cho (pone.0323450.ref008) 2021; 8 IJ Cho (pone.0323450.ref017) 2022; 40 L Wang (pone.0323450.ref026) 2023; 2023 H Yang (pone.0323450.ref014) 2024; 11 R Ali (pone.0323450.ref022) 2019; 42 J-X Li (pone.0323450.ref027) 2022; 22 EA Eisenhauer (pone.0323450.ref012) 2009; 45 SB Paul (pone.0323450.ref016) 2019; 54 S Park (pone.0323450.ref005) 2020; 26 Y-M Huang (pone.0323450.ref025) 2022; 12 J Yoo (pone.0323450.ref020) 2020; 40 L Lu (pone.0323450.ref013) 2022; 47 R Lencioni (pone.0323450.ref009) 2017; 66 SY Hong (pone.0323450.ref002) 2022; 26 Liver European Association for the Study of the (pone.0323450.ref003) 2018; 69 N Tayob (pone.0323450.ref029) 2023; 21 BA Dyer (pone.0323450.ref024) 2017; 44 M Kong (pone.0323450.ref023) 2015; 34 Korea Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) (pone.0323450.ref004) 2022; 28 DY Kim (pone.0323450.ref011) 2023; 29 JS Yoon (pone.0323450.ref019) 2019; 11 WI Chang (pone.0323450.ref007) 2022; 37 NK Lee (pone.0323450.ref010) 2016; 6 N Tanabe (pone.0323450.ref018) 2023; 15 RX Zhu (pone.0323450.ref001) 2016; 10 Ł Masior (pone.0323450.ref015) 2023; 15 |
| References_xml | – volume: 28 start-page: 583 issue: 4 year: 2022 ident: pone.0323450.ref004 article-title: 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma publication-title: Clin Mol Hepatol doi: 10.3350/cmh.2022.0294 – volume: 26 start-page: 211 issue: 3 year: 2022 ident: pone.0323450.ref002 article-title: Incidence, mortality, and survival of liver cancer using Korea central cancer registry database: 1999–2019 publication-title: Ann Hepatobiliary Pancreat Surg doi: 10.14701/ahbps.22-044 – volume: 45 start-page: 228 issue: 2 year: 2009 ident: pone.0323450.ref012 article-title: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) publication-title: Eur J Cancer doi: 10.1016/j.ejca.2008.10.026 – volume: 6 start-page: 731 issue: 3 year: 2016 ident: pone.0323450.ref010 article-title: The sequential change of MRI signal intensity in normal liver after radiotherapy for hepatocellular carcinoma publication-title: J Med Imag Health In – volume: 69 start-page: 182 issue: 1 year: 2018 ident: pone.0323450.ref003 article-title: EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma publication-title: J Hepatol doi: 10.1016/j.jhep.2018.03.019 – volume: 47 start-page: 101391 year: 2022 ident: pone.0323450.ref013 article-title: Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study publication-title: EClinicalMedicine doi: 10.1016/j.eclinm.2022.101391 – volume: 15 start-page: 2927 issue: 11 year: 2023 ident: pone.0323450.ref018 article-title: Early prediction of response focused on tumor markers in atezolizumab plus bevacizumab therapy for hepatocellular carcinoma publication-title: Cancers (Basel) doi: 10.3390/cancers15112927 – volume: 10 start-page: 332 issue: 3 year: 2016 ident: pone.0323450.ref001 article-title: Epidemiology of hepatocellular carcinoma in the Asia-Pacific region publication-title: Gut Liver – volume: 11 start-page: 1295 issue: 9 year: 2019 ident: pone.0323450.ref021 article-title: Comparison of models for tumor recurrence after liver transplantation for the patients with hepatocellular carcinoma: A multicenter long-term follow-up study publication-title: Cancers (Basel) doi: 10.3390/cancers11091295 – volume: 40 start-page: 1189 issue: 5 year: 2020 ident: pone.0323450.ref020 article-title: Evaluation of a serum tumour marker-based recurrence prediction model after radiofrequency ablation for hepatocellular carcinoma publication-title: Liver Int doi: 10.1111/liv.14406 – volume: 8 start-page: 613 year: 2021 ident: pone.0323450.ref008 article-title: Clinical characteristics of long-term survivors after sorafenib treatment for unresectable hepatocellular carcinoma: A Korean national multicenter retrospective cohort study publication-title: J Hepatocell Carcinoma doi: 10.2147/JHC.S304439 – volume: 66 start-page: 1166 issue: 6 year: 2017 ident: pone.0323450.ref009 article-title: Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC publication-title: J Hepatol doi: 10.1016/j.jhep.2017.01.012 – volume: 42 start-page: 700 issue: 5 year: 2019 ident: pone.0323450.ref022 article-title: Prognosticating survival in hepatocellular carcinoma with elevated baseline alpha-fetoprotein treated with radioembolization using a novel laboratory scoring system: initial development and validation publication-title: Cardiovasc Intervent Radiol doi: 10.1007/s00270-019-02191-z – volume: 40 start-page: 20 issue: 1 year: 2022 ident: pone.0323450.ref017 article-title: PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy publication-title: Radiat Oncol J doi: 10.3857/roj.2021.00934 – volume: 22 start-page: 510 issue: 1 year: 2022 ident: pone.0323450.ref027 article-title: Prognostic value of a nomogram based on peripheral blood immune parameters in unresectable hepatocellular carcinoma after intensity-modulated radiotherapy publication-title: BMC Gastroenterol doi: 10.1186/s12876-022-02596-0 – volume: 54 start-page: 1132 issue: 9 year: 2019 ident: pone.0323450.ref016 article-title: Prognostic role of serial alpha-fetoprotein levels in hepatocellular carcinoma treated with locoregional therapy publication-title: Scand J Gastroenterol doi: 10.1080/00365521.2019.1660403 – volume: 29 start-page: 277 issue: 2 year: 2023 ident: pone.0323450.ref011 article-title: Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region publication-title: Clin Mol Hepatol doi: 10.3350/cmh.2022.0212 – volume: 15 start-page: 3962 issue: 15 year: 2023 ident: pone.0323450.ref015 article-title: Alpha-fetoprotein response after first transarterial chemoembolization (TACE) and complete pathologic response in patients with hepatocellular cancer publication-title: Cancers (Basel) doi: 10.3390/cancers15153962 – volume: 44 start-page: 303 issue: 5 year: 2017 ident: pone.0323450.ref024 article-title: Surveillance imaging following definitive radiotherapy for non-small cell lung cancer: What is the clinical impact? publication-title: Semin Oncol doi: 10.1053/j.seminoncol.2018.01.007 – volume: 21 issue: 2 year: 2023 ident: pone.0323450.ref029 article-title: The performance of AFP, AFP-3, DCP as biomarkers for detection of hepatocellular carcinoma (HCC): A phase 3 biomarker study in the United States publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2022.01.047 – volume: 11 start-page: 1721 issue: 11 year: 2019 ident: pone.0323450.ref019 article-title: Tumor marker-based definition of the transarterial chemoembolization-refractoriness in intermediate-stage hepatocellular carcinoma: A multi-cohort study publication-title: Cancers (Basel) doi: 10.3390/cancers11111721 – volume: 79 start-page: 1469 issue: 6 year: 2023 ident: pone.0323450.ref028 article-title: Afp-l3 and dcp strongly predict early hepatocellular carcinoma recurrence after liver transplantation publication-title: J Hepatol doi: 10.1016/j.jhep.2023.08.020 – volume: 11 start-page: 219 year: 2024 ident: pone.0323450.ref014 article-title: A longitudinal study of AFP trajectories and clinical outcomes in intermediate-stage hepatocellular carcinoma after hepatectomy publication-title: J Hepatocell Carcinoma doi: 10.2147/JHC.S432011 – volume: 12 start-page: 906498 year: 2022 ident: pone.0323450.ref025 article-title: Radiomics-based nomogram as predictive model for prognosis of hepatocellular carcinoma with portal vein tumor thrombosis receiving radiotherapy publication-title: Front Oncol doi: 10.3389/fonc.2022.906498 – volume: 34 start-page: 79 issue: 2 year: 2015 ident: pone.0323450.ref023 article-title: Optimal follow-up duration for evaluating objective response to radiotherapy in patients with hepatocellular carcinoma: a retrospective study publication-title: Chin J Cancer doi: 10.5732/cjc.014.10136 – volume: 26 start-page: 393 issue: 4 year: 2020 ident: pone.0323450.ref005 article-title: Indications of external radiotherapy for hepatocellular carcinoma from updated clinical guidelines: Diverse global viewpoints publication-title: World J Gastroenterol doi: 10.3748/wjg.v26.i4.393 – volume: 16 start-page: 1368 issue: 6 year: 2022 ident: pone.0323450.ref006 article-title: Radiotherapy prior to or after transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a randomized controlled trial publication-title: Hepatol Int doi: 10.1007/s12072-022-10423-7 – volume: 37 start-page: 387 issue: 2 year: 2022 ident: pone.0323450.ref007 article-title: Role of radiotherapy in Barcelona clinic liver cancer stage C hepatocellular carcinoma treated with sorafenib publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.15722 – volume: 2023 start-page: 1554599 year: 2023 ident: pone.0323450.ref026 article-title: Prognostic value of a CT radiomics-based nomogram for the overall survival of patients with nonmetastatic BCLC stage C hepatocellular carcinoma after stereotactic body radiotherapy publication-title: J Oncol doi: 10.1155/2023/1554599 |
| SSID | ssj0053866 |
| Score | 2.4786906 |
| Snippet | Signal changes after high dose irradiation on MRI make it difficult to assess the therapeutic response of hepatocellular carcinoma (HCC). To overcome the... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | e0323450 |
| SubjectTerms | Adult Aged alpha-Fetoproteins - metabolism Biology and Life Sciences Biomarkers Biomarkers, Tumor - blood Biomarkers, Tumor - metabolism Blood clots Carcinoma, Hepatocellular - blood Carcinoma, Hepatocellular - metabolism Carcinoma, Hepatocellular - mortality Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - radiotherapy Care and treatment Chemotherapy Clinical outcomes Female Hepatitis B Hepatocellular carcinoma Hepatoma Humans Irradiation Liver cancer Liver Neoplasms - blood Liver Neoplasms - metabolism Liver Neoplasms - mortality Liver Neoplasms - pathology Liver Neoplasms - radiotherapy Magnetic resonance imaging Male Measurement Medical prognosis Medicine and Health Sciences Metastasis Middle Aged Multivariate analysis Patient outcomes Patients Physical Sciences Portal vein Prognosis Protein Precursors Prothrombin - metabolism Radiation dosage Radiation therapy Radiotherapy Remission Research and Analysis Methods Retrospective Studies Sensitivity Simulation Thrombosis Treatment Outcome Tumor markers Tumors |
| SummonAdditionalLinks | – databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZg4cCFUl5NKWAQEnBI69hZOzmhgqhAQmXFo-otchynXYmNlySLtHd-ODOJszSoQkhc15Ns4nnHM98Q8kwmwgJzdWjAvYdxWegw0WkZQqRdWKnLadpNUTj5oI6Pk9PTdOY_uDW-rHKwiZ2hLpzBb-QHgqPzFVLFr5bfQ5wahaerfoTGVXINURJEV7o3Gywx6LKUvl1OqOjAc2d_6Sq7zwQXMXbbX3BHHWr_xjZPlt9cc1ng-Wf95AWHdLT1v69yi9z0oSg97GVnm1yx1W2y7ZW9oS88IvXLO-TnrMbznLbH9F5TV9Kho5K6VQv_CvTdtHE6oErT3OoFrXUx9y1eawrhMT0H79c6PC3A8ldqcJJR5RaaaoNpMPhR2jrarhZAu8DKoZoW60ov5qa5S74evf3y5l3oxzeEBoKsNlS6UMJCBspyzlIrueFSFUxYDWFHlBbptEy4zkub5DzRyirDUmUgvZGKc8VScY9MKmDVDoFHjsCwgLs1kECpmCUWokAtWQ4Bj7KpCkg4cDFb9igdWXdUpyC76XczQ65nnusBeY2s3tAixnb3g6vPMq-ycLVkPOUaS1ZjG021Enke5bJkZcmTCG7yGAUl6xtWN5YiO4ScWcqESR6Qpx0F4mxUWMhzpldNk73_ePIPRJ8_jYiee6LSgcgZ7Zsn4J0Qv2tEuTeiBGthRss7KNbDrjTZb2GEKwdxvXz5yWYZb4rFeZV1q56GCzDmMiD3e83Y7GzMIACHrD4gyUhnRls_Xqnm5x3MOXZ1A9vF7t-f6wG5wXEmM5uCxd8jk7Ze2YfkuvnRzpv6UWcQfgEnvmsQ priority: 102 providerName: ProQuest – databaseName: Public Library of Science (PLoS) Journals Open Access dbid: FPL link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELbQwoELtLy6tIBBSMAhrWNn7eRYECuQqrLiUfUWOY5DVyLJKg-kvfPDmUmcQKpWgut6HHnn-Y08MybkpQyFBeFqz0B494Is1V6oo8wDpJ1aqbNF1L2icHaiTk_D8_No9SdRvHSDL5R_5Hh6uCkLe8gEFwGm6De5kBJLuJark8Hzgu1K6drjrts5CT_dlP7RF882P8r6KqB5uV7yrwC0vPu_R98hdxzUpMe9buySG7a4R3adMdf0tZs4_eY--bWq8L6m6Wd2b2mZ0aFjkpZtA0oJ9N1r4nSYGk0Tq3Na6XTtWri2FOAvvYDo1pR4G4DlrdTgS0VFmWuqDaa5ECdpU9KmzYE2x8qgiqbbQudrUz8g35bvv7774LnnGTwDIKrxlE6VsJBhsoSzyEpuuFQpE1YDrPCjNFpkIddJZsOEh1pZZVikDKQvUnGuWCQeklkBnNkjcGQfHAeEUwMJkgpYaAHlackSADTKRmpOvEFq8aafwhF3V3EKspeemzEyOXZMnpO3KNqRFmdodz-AdGJnkrBbMh5xjSWpgfUXWokk8ROZsSzjoQ8feYaKEfcNqaMniI8hJwbdY5LPyYuOAudoFFio8123dR1__HT2D0RfPk-IXjmirAQVM9o1R8B_wvlcE8qDCSV4AzNZ3kM1HrhSx4IjaBVSBbBzUO2rl5-Py_hRLL4rbNn2NFyAs5Zz8qi3hJGzAQOADVn7nIQTG5mwfrpSrC-6MebYtQ1iF4-vP_I-uc3xvWW2AG9-QGZN1don5Jb52azr6mln_L8Bs4VZXA priority: 102 providerName: Public Library of Science |
| Title | Predictability of clinical outcomes after external beam radiotherapy for hepatocellular carcinoma according to tumor marker dynamics |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/40392828 https://www.proquest.com/docview/3206153674 https://www.proquest.com/docview/3206235316 https://pubmed.ncbi.nlm.nih.gov/PMC12091783 https://doaj.org/article/1360292a10744e15a73bb1b6f0ff2810 http://dx.doi.org/10.1371/journal.pone.0323450 |
| Volume | 20 |
| WOSCitedRecordID | wos001492085500049&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: DOA dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M~E dateStart: 20060101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Advanced Technologies & Aerospace Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: P5Z dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/hightechjournals providerName: ProQuest – providerCode: PRVPQU databaseName: Agricultural Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M0K dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/agriculturejournals providerName: ProQuest – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M7P dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Engineering Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M7S dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com providerName: ProQuest – providerCode: PRVPQU databaseName: Environmental Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: PATMY dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/environmentalscience providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 7X7 dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Materials Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: KB. dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/materialsscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 7RV dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: BENPR dateStart: 20061201 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: PIMPY dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 8C1 dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVATS databaseName: Public Library of Science (PLoS) Journals Open Access customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: FPL dateStart: 20060101 isFulltext: true titleUrlDefault: http://www.plos.org/publications/ providerName: Public Library of Science |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9MwFLegcOCCGF8LjGIQEnBI59ip7RzXaRXTthJ1UJVdIidxWCWaVE2KtDt_OM9xUjVoEhy4vEP8EqXvPT__XvM-EHrHJdOgXOUmcLy7fpYqV6ogcwFpp5qrbBjUUxRm52IykfN5EO6M-jI5YbY9sBXcocc4oQFVJnHQ195QCRbHXswzkmVU2uIqQD1tMGV9MOxizptCOSa8w0Yvg1WR6wFhlPmmzn7nIKr79W-9cm_1oyhvg5x_Zk7uHEXjR-hhgyHxkX33PXRH54_RXrNLS_yhaSX98Qn6Fa7Nh5jKNuO-wUWG21JIXGwqsDbgr8eE47YdNI61WuK1ShdNbdYNBlyLr-HYqgrzN7_JW8WJGUGUF0uFVWLiVzgAcVXgarME3qVJ-Vnj1A67L5-ir-OTL8ef3GbugpsAOqpcoVLBNISOJKYk0JwmlIuUMK0AL3hBGgwzSVWcaRlTqYQWCQlEAnEJF5QKErBnqJeDpPcRvLIHHgHOyQQiH-ETqQG-KU5iQCpCB8JBbquEaGXba0T1NzYBYYmVZmSUFjVKc9DIaGrLa5pj1xfAZKLGZKK_mYyDXhs9R7bSdLvFoyMIdjmXhFMHva05TIOM3GTgfFebsoxOP8_-gely2mF63zBlBVhMopqqB_hNpvFWh_OgwwnbPOks7xurbKVSRowaNMq48OHO1lJvX36zXTYPNVl1uS42locy8MLcQc-tYW8l6xNAzhCOO0h2TL4j-u5Kvriu-5ObcmxQO3vxP5T1Ej2gZuQyGYJDP0C9ar3Rr9D95Ge1KNd9dFdMZ4bORU0lUHns9dG90ckknPZrrwB0HJ4DPRsNgF6QM0NFWNNLoOHwCu4ITy_Cb78BacdoZw |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELaqggQXoLy6UKhBIOCQ1nGytnNAqDyqrrosVSmr3oLjOO1KbLIkWdDe-T38RmbyWBpUIS49cI0nUTKe-WYmngchT4TyLGyudgyYd8dPYu0oHSQOeNqxFTrpB9UUhfFQjkbq-Dg4WCE_21oYTKtsMbEC6jgz-I982-NofD0h_Vezrw5OjcLT1XaERi0W-3bxHUK24uXgLezvU8533x292XOaqQKOAdtfOlLH0rMQGLGIs8AKbriQMfOsBmvoBnHQTxTXUWJVxJWWVhoWSANet5Ccy6r5EkD-JcBxF1PI5OG4RX7ADiGa8jxPutuNNGzNstRuMY97Plb3nzF_1ZSApS1YnX3JivMc3T_zNc8YwN3r_xvrbpBrjatNd2rdWCMrNr1J1howK-jzpuP2i1vkx0GO51Vl3bN8QbOEthWjNJuX8JVAX01Tp23XbBpZPaW5jidNCduCgvtPT8G6lxmehmB6LzU4qSnNpppqg2E--Am0zGg5nwLtFDOjchovUj2dmOI2-XQh3LhDVlMQjXUCr-wCcII7YSBAlD5TFrxcLVgEDp20gewRp5WacFZ3IQmro0gJ0VvNzRClLGykrEdeo2gtabGHeHUhy0_CBpLgbsF4wDWm5PrW7WvpRZEbiYQlCVcuPGQTBTOsC3KXSBjuKHAChWKC98jjigL7iKSYqHSi50URDj6M_4Ho42GH6FlDlGQg4kY3xSHwTdifrEO50aEENDSd5XVUo5YrRfhb-OHOVj3OX360XMaHYvJharN5TcM9MFaiR-7WmrjkrM8gwFBc9Yjq6GiH9d2VdHJatXHHqnXYdu_e399rk1zZO3o_DIeD0f59cpXj_GnWB-u2QVbLfG4fkMvmWzkp8ocVGFHy-aJV-BdZH8XK |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELaqghAXoLy6UKhBIOCQrtfJ2s4BodKyYtVqWfGoeguO47QrscmSZEF751fx65jJiwZViEsPXONJlIy_ecXzIOSJUK6FzdWOAfPueHGkHaX92AFPO7JCx0O_nKJwdCgnE3V87E_XyM-mFgbTKhudWCrqKDX4j7zvcjS-rpBeP67TIqb7o1eLrw5OkMKT1macRgWRA7v6DuFb_nK8D3v9lPPRm497b516woBjwA8oHKkj6VoIkljImW8FN1zIiLlWg2Uc-JE_jBXXYWxVyJWWVhrmSwMeuJCcy7IRE6j_S9IFFGOV-l6bXgJ6RIi6VM-Vg36NjJ1Fmtgd5nLXw0r_M6awnBjQ2oX1xZc0P8_p_TN384wxHF3_n9l4g1yrXXC6W8nMBlmzyU2yUSu5nD6vO3G_uEV-TDM8xyqqXuYrmsa0qSSl6bKALwb6cso6bbpp09DqOc10NKtL21YUwgJ6Cla_SPGUBNN-qcEJTkk611QbDP_Bf6BFSovlHGjnmDGV0WiV6PnM5LfJpwvhxh2yngBMNgm88gAUKrgZBgJH6TFlwfvVgoXg6Enryx5xGgQFi6o7SVAeUUqI6ipuBoi4oEZcj7xGmLW02Fu8vJBmJ0GtquBuwbjPNabqenYw1NINw0EoYhbHXA3gIdsI0qAq1G01ZLCrwDkUigneI49LCuwvkiDETvQyz4Pxu6N_IPrwvkP0rCaKU4C70XXRCHwT9i3rUG51KEFLms7yJopUw5U8-C0IcGcjKucvP2qX8aGYlJjYdFnRcBeMmOiRu5VUtpz1GAQeiqseUR157bC-u5LMTsv27ljNDtvu3vv7e22TKyC5weF4cnCfXOU4lpoNwehtkfUiW9oH5LL5Vszy7GGplyj5fNES_Asq5s4l |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predictability+of+clinical+outcomes+after+external+beam+radiotherapy+for+hepatocellular+carcinoma+according+to+tumor+marker+dynamics&rft.jtitle=PloS+one&rft.au=Park%2C+Sunmin&rft.au=Rim%2C+Chai+Hong&rft.au=Jung%2C+Young+Kul&rft.au=Yim%2C+Hyung+Joon&rft.date=2025-05-20&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=20&rft.issue=5&rft_id=info:doi/10.1371%2Fjournal.pone.0323450&rft.externalDocID=PMC12091783 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |